Biohaven Pharmaceuticals Inc.   Report issue

Founded: New Haven CT United States (2014)
Status: Acquired by Pfizer (2022)

Organization Overview

First Clinical Trial
2016
NCT02960893
First Marketed Drug
2020
rimegepant (Nurtec)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BIOHAVEN IRELAND | BIOHAVEN PHARM | Biohaven Pharmaceutical Holding Company Ltd. | Biohaven Pharmaceuticals, Inc. | Biohaven Therapeutics Ltd.